Patient-Controlled Subcutaneous Sufentanil Bests Morphine in Advanced Cancer Patient-Controlled Subcutaneous Sufentanil Bests Morphine in Advanced Cancer

In patients with stage III-IV cancer, patient-controlled subcutaneous analgesia (PCSA) with sufentanil led to better pain control and quality of life than morphine in a randomized trial.Reuters Health Information

Source: Medscape Medical News Headlines - June 17, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news